Amanote Research
Register
Sign In
BRAF-Like Colorectal Cancer Cells Are Selectively Dependent on RANBP2
Cancer Discovery
- United States
doi 10.1158/2159-8290.cd-rw2016-071
Full Text
Open PDF
Abstract
Available in
full text
Categories
Oncology
Date
April 21, 2016
Authors
Unknown
Publisher
American Association for Cancer Research (AACR)
Related search
Mutated in Colorectal Cancer, a Putative Tumor Suppressor for Serrated Colorectal Cancer, Selectively Represses Β-Catenin-Dependent Transcription
Oncogene
Cancer Research
Genetics
Molecular Biology
B-Raf Inhibitors Induce Epithelial Differentiation in BRAF-Mutant Colorectal Cancer Cells
Cancer Research
Cancer Research
Oncology
BRAF V600E Mutant Colorectal Cancer Subtypes Based on Gene Expression
Clinical Cancer Research
Cancer Research
Oncology
RAS and BRAF in Metastatic Colorectal Cancer Management
Journal of Gastrointestinal Oncology
Oncology
Gastroenterology
BRAF Mutation as a Biomarker in Colorectal Cancer
Advances in Genomics and Genetics
BRAF-mutated Metastatic Colorectal Cancer Between Past and Future
British Journal of Cancer
Cancer Research
Oncology
Pilot Trial of Combined BRAF and EGFR Inhibition in BRAF-Mutant Metastatic Colorectal Cancer Patients
Clinical Cancer Research
Cancer Research
Oncology
Glucose-Dependent Insulinotropic Polypeptide Stimulates the Proliferation of Colorectal Cancer Cells
Regulatory Peptides
T Cell-Engaging BiTE Antibodies Specific for EGFR Potently Eliminate KRAS- And BRAF-mutated Colorectal Cancer Cells
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
